ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

NCI Programs: Study Finds Bomb Tests Raised I-131 Exposure in 1950’s, 1960’s

August 22, 1997

Pitot Supports Clearinghouse Modifications

January 20, 1978

In Brief: Vicent Bono Retires As Investigational Drugs Branch Chief; Weiss to Leave For Walter Reed

January 9, 1981

In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch

June 23, 1995